Alembics product pipeline for FY22 is quite strong: Rajkumar Kumar Baheti, CFO

Rajkumar Kumar Baheti, CFO, Alembic Pharmaceuticals, talks about the pressure on Sartans sales in the US, Outlook on India business, RBIs announcement for COVID related healthcare infra, API business, cancer drug Umbrasilib and bottom line and margin guidance for FY22 among others during an exclusive interview with Zee Business Swati Khandelwal